- Home
- MREO vs COFS Comparison
MREO vs COFS Comparison
Compare MREO & COFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- COFS
- Stock Information
- Founded
- MREO 2015
- COFS 1898
- Country
- MREO United Kingdom
- COFS United States
- Employees
- MREO N/A
- COFS N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- COFS Major Banks
- Sector
- MREO Health Care
- COFS Finance
- Exchange
- MREO Nasdaq
- COFS Nasdaq
- Market Cap
- MREO 369.2M
- COFS 304.4M
- IPO Year
- MREO N/A
- COFS N/A
- Fundamental
- Price
- MREO $2.26
- COFS $28.77
- Analyst Decision
- MREO Strong Buy
- COFS Strong Buy
- Analyst Count
- MREO 7
- COFS 2
- Target Price
- MREO $7.71
- COFS $39.00
- AVG Volume (30 Days)
- MREO 1.2M
- COFS 56.6K
- Earning Date
- MREO 03-26-2025
- COFS 04-23-2025
- Dividend Yield
- MREO N/A
- COFS 3.89%
- EPS Growth
- MREO N/A
- COFS 15.25
- EPS
- MREO N/A
- COFS 3.25
- Revenue
- MREO N/A
- COFS $91,112,000.00
- Revenue This Year
- MREO N/A
- COFS $77.46
- Revenue Next Year
- MREO $69.09
- COFS $10.95
- P/E Ratio
- MREO N/A
- COFS $8.85
- Revenue Growth
- MREO N/A
- COFS 12.98
- 52 Week Low
- MREO $2.16
- COFS $21.52
- 52 Week High
- MREO $5.02
- COFS $38.15
- Technical
- Relative Strength Index (RSI)
- MREO 33.19
- COFS 32.58
- Support Level
- MREO $2.23
- COFS $28.25
- Resistance Level
- MREO $2.73
- COFS $29.79
- Average True Range (ATR)
- MREO 0.14
- COFS 0.77
- MACD
- MREO -0.01
- COFS 0.13
- Stochastic Oscillator
- MREO 7.89
- COFS 43.06
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About COFS ChoiceOne Financial Services Inc.
ChoiceOne Financial Services Inc is a full-service banking institution. It is engaged in the business of providing personal and business banking solutions, borrowing solutions, and treasury notes and bonds services. The bank's product and services portfolio consist of time, savings and demand deposits, safe deposit services, automated transaction machine services, commercial and consumer loans, commercial lending to business, industry, agricultural, construction, inventory, and real estate categories. Its primary market area is Kent, Muskegon, Newaygo, and Ottawa counties in western Michigan, and Lapeer, Macomb, and St. Clair counties in southeastern Michigan in the communities where the Bank's respective offices are located.